Aerosolized Beractant in neonatal respiratory distress syndrome: A randomized fixed-dose parallel-arm phase II trial
Authors:
- 1 February 2021
- journal article
- research article
- Published by Elsevier in Pulmonary Pharmacology & Therapeutics
- Vol. 66, 101986
Abstract
No abstract availableKeywords
Funding Information
- U.S. Food and Drug Administration
This publication has 49 references indexed in Scilit:
- A tutorial on sensitivity analyses in clinical trials: the what, why, when and howBMC Medical Research Methodology, 2013
- Surfactant Administration via Thin Catheter During Spontaneous Breathing: Randomized Controlled TrialPediatrics, 2013
- Therapeutic effects of inhaling aerosolized surfactant alone or with dexamethasone generated by a novel noninvasive apparatus on acute lung injury in ratsJournal of Trauma and Acute Care Surgery, 2012
- The non-intubated, spontaneously breathing, continuous positive airway pressure (CPAP) ventilated pre-term lamb: A unique animal modelReproductive Toxicology, 2012
- How best to administer surfactant to VLBW infants?Archives of Disease in Childhood - Fetal and Neonatal Edition, 2011
- An Open Label, Pilot Study of Aerosurf ® Combined with nCPAP to Prevent RDS in Preterm NeonatesJournal of Aerosol Medicine and Pulmonary Drug Delivery, 2010
- Aerosolised surfactant generated by a novel noninvasive apparatus reduced acute lung injury in ratsCritical Care, 2009
- Pilot study of nebulized surfactant therapy for neonatal respiratory distress syndromeActa Paediatrica, 2000
- Determinants of Aerosolized Albuterol Delivery to Mechanically Ventilated InfantsChest, 1996
- The CRIB (clinical risk index for babies) score: a tool for assessing initial neonatal risk and comparing performance of neonatal intensive care unitsThe Lancet, 1993